Article
In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression
4 Apr 2011
Abstract excerpt
UNLABELLED: Interleukin-22 (IL-22), which acts as either a proinflammatory or anti-inflammatory cytokine in various disease models, is markedly up-regulated in chronic liver diseases, including hepatitis B and C. In this report, we demonstrate a strong correlation between IL-22 expression in the liver with active, inflammatory human liver disease. To clarify the role of IL-22 up-regulation in the pathogenesis of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
